Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
|Articles|January 12, 2021
The 10 Best States for Physicians
Author(s)Drew Boxler , Logan Lutton
Some states that are better for physicians than others in terms of finances, competition, and other criteria. Partner site Physicians Practice crunched the numbers for you.
Advertisement
Editor's Note: this slide show originally appeared on our partner publication, Physicians Practice©
What are the best states for physicians?
Like most things in life, choosing where to practice medicine comes with pros, cons and trade-offs. Some physicians want to practice in a big city, others a one-stoplight town — and everything in between.
But besides personal and lifestyle reasons, there are some states that are better for physicians than others in terms of finances, competition, and other criteria.
In the 2020 Best States to Practice project, our partner publication Physicians Practice compiled some publicly available data to provide a perspective on what states can be best described as “physician-friendly.”
For our analysis, our editors ranked the states based on 2019 data covering 5 categories:
Average salary
Tax climate (state collections per capita)
Highest/lowest malpractice premiums
The 2019 cost of living index
Physician density
Physicians Practice obtained the data from publicly available sources.
The list should not be taken as ranking which states are better than others. It simply provides physicians with some objective data they can use when making their career decisions.
See the entire Best States to Practice at Physicians Practice’s website.
Advertisement
Related to this article
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
TMS 2026: Menopause was coded in just 7.8% of midlife outpatient visits. Arina Chesnokova, MD, MPH, discusses diagnosis gaps, prescribing risks, and solutions for primary care.
Advertisement
Advertisement